Literature DB >> 22038473

Physicochemical characterization and water vapor sorption of organic solution advanced spray-dried inhalable trehalose microparticles and nanoparticles for targeted dry powder pulmonary inhalation delivery.

Xiaojian Li1, Heidi M Mansour.   

Abstract

Novel advanced spray-dried inhalable trehalose microparticulate/nanoparticulate powders with low water content were successfully produced by organic solution advanced spray drying from dilute solution under various spray-drying conditions. Laser diffraction was used to determine the volumetric particle size and size distribution. Particle morphology and surface morphology was imaged and examined by scanning electron microscopy. Hot-stage microscopy was used to visualize the presence/absence of birefringency before and following particle engineering design pharmaceutical processing, as well as phase transition behavior upon heating. Water content in the solid state was quantified by Karl Fisher (KF) coulometric titration. Solid-state phase transitions and degree of molecular order were examined by differential scanning calorimetry (DSC) and powder X-ray diffraction, respectively. Scanning electron microscopy showed a correlation between particle morphology, surface morphology, and spray drying pump rate. All advanced spray-dried microparticulate/nanoparticulate trehalose powders were in the respirable size range and exhibited a unimodal distribution. All spray-dried powders had very low water content, as quantified by KF. The absence of crystallinity in spray-dried particles was reflected in the powder X-ray diffractograms and confirmed by thermal analysis. DSC thermal analysis indicated that the novel advanced spray-dried inhalable trehalose microparticles and nanoparticles exhibited a clear glass transition (T(g)). This is consistent with the formation of the amorphous glassy state. Spray-dried amorphous glassy trehalose inhalable microparticles and nanoparticles exhibited vapor-induced (lyotropic) phase transitions with varying levels of relative humidity as measured by gravimetric vapor sorption at 25°C and 37°C.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22038473      PMCID: PMC3225514          DOI: 10.1208/s12249-011-9704-0

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  32 in total

Review 1.  Inhaling medicines: delivering drugs to the body through the lungs.

Authors:  John S Patton; Peter R Byron
Journal:  Nat Rev Drug Discov       Date:  2007-01       Impact factor: 84.694

Review 2.  Raman characterization and chemical imaging of biocolloidal self-assemblies, drug delivery systems, and pulmonary inhalation aerosols: a review.

Authors:  Heidi M Mansour; Anthony J Hickey
Journal:  AAPS PharmSciTech       Date:  2007-11-30       Impact factor: 3.246

3.  Micro-particle corrugation, adhesion and inhalation aerosol efficiency.

Authors:  Santoso Adi; Handoko Adi; Patricia Tang; Daniela Traini; Hak-Kim Chan; Paul M Young
Journal:  Eur J Pharm Sci       Date:  2008-06-08       Impact factor: 4.384

Review 4.  Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification.

Authors:  A L Katzenstein; J L Myers
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

5.  Aerosolized antibiotics in cystic fibrosis.

Authors:  William P Sexauer; Stanley B Fiel
Journal:  Semin Respir Crit Care Med       Date:  2003-12       Impact factor: 3.119

6.  Stability and freeze-drying of cyclosporine loaded poly(D,L lactide-glycolide) carriers.

Authors:  M Chacón; J Molpeceres; L Berges; M Guzmán; M R Aberturas
Journal:  Eur J Pharm Sci       Date:  1999-05       Impact factor: 4.384

7.  The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-IgE monoclonal antibody.

Authors:  J D Andya; Y F Maa; H R Costantino; P A Nguyen; N Dasovich; T D Sweeney; C C Hsu; S J Shire
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

8.  Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone).

Authors:  Patrick J Marsac; Alfred C F Rumondor; David E Nivens; Umesh S Kestur; Lia Stanciu; Lynne S Taylor
Journal:  J Pharm Sci       Date:  2010-01       Impact factor: 3.534

9.  Alternative sugars as potential carriers for dry powder inhalations.

Authors:  Hartwig Steckel; Nina Bolzen
Journal:  Int J Pharm       Date:  2004-02-11       Impact factor: 5.875

10.  Aerosolization properties, surface composition and physical state of spray-dried protein powders.

Authors:  Cynthia Bosquillon; Paul G Rouxhet; François Ahimou; Denis Simon; Christine Culot; Véronique Préat; Rita Vanbever
Journal:  J Control Release       Date:  2004-10-19       Impact factor: 9.776

View more
  19 in total

1.  Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.

Authors:  Xiaojian Li; Frederick G Vogt; Don Hayes; Heidi M Mansour
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2014-02-06       Impact factor: 2.849

2.  Microparticulate/Nanoparticulate Powders of a Novel Nrf2 Activator and an Aerosol Performance Enhancer for Pulmonary Delivery Targeting the Lung Nrf2/Keap-1 Pathway.

Authors:  Priya Muralidharan; Don Hayes; Stephen M Black; Heidi M Mansour
Journal:  Mol Syst Des Eng       Date:  2016-01-27

3.  Formulation and characterization of inhalable magnetic nanocomposite microparticles (MnMs) for targeted pulmonary delivery via spray drying.

Authors:  Nathanael A Stocke; Samantha A Meenach; Susanne M Arnold; Heidi M Mansour; J Zach Hilt
Journal:  Int J Pharm       Date:  2014-12-24       Impact factor: 5.875

4.  Evaluation of granulated lactose as a carrier for DPI formulations 1: effect of granule size.

Authors:  Ping Du; Ju Du; Hugh D C Smyth
Journal:  AAPS PharmSciTech       Date:  2014-06-25       Impact factor: 3.246

5.  Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer.

Authors:  Samantha A Meenach; Kimberly W Anderson; J Zach Hilt; Ronald C McGarry; Heidi M Mansour
Journal:  Eur J Pharm Sci       Date:  2013-05-23       Impact factor: 4.384

6.  Trehalose glycopolymers as excipients for protein stabilization.

Authors:  Juneyoung Lee; En-Wei Lin; Uland Y Lau; James L Hedrick; Erhan Bat; Heather D Maynard
Journal:  Biomacromolecules       Date:  2013-07-01       Impact factor: 6.988

7.  Synthesis and Characterization of Nanocomposite Microparticles (nCmP) for the Treatment of Cystic Fibrosis-Related Infections.

Authors:  Zimeng Wang; Samantha A Meenach
Journal:  Pharm Res       Date:  2016-04-18       Impact factor: 4.200

8.  Responsive Hydrogel Nanoparticles for Pulmonary Delivery.

Authors:  Nathanael A Stocke; Susanne M Arnold; J Zach Hilt
Journal:  J Drug Deliv Sci Technol       Date:  2015-10-01       Impact factor: 3.981

9.  Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols.

Authors:  Samantha A Meenach; Frederick G Vogt; Kimberly W Anderson; J Zach Hilt; Ronald C McGarry; Heidi M Mansour
Journal:  Int J Nanomedicine       Date:  2013-01-15

10.  Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried cyclosporine A multifunctional particles for dry powder inhalation aerosol delivery.

Authors:  Xiao Wu; Weifen Zhang; Don Hayes; Heidi M Mansour
Journal:  Int J Nanomedicine       Date:  2013-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.